SOURCE: Informa


September 21, 2015 12:18 ET

PSA: Pharmaceutical Strategy Conference Is Coming to NYC on September 28-30

NEW YORK, NY--(Marketwired - September 21, 2015) - PSA: The Pharmaceutical Strategy Conference is taking place in New York City from September 28-30 at the Marriott Marquis. PSA serves as a platform for top pharmaceutical and biotech companies to converge and solve the fundamental challenges facing industry growth. An unparalleled opportunity to build professional connections, current attending companies include Bayer, Teva Pharmaceuticals, Sanofi, Roche, Pfizer, Bristol-Myers Squibb, Regeneron Pharmaceuticals, Actavis, Merck, AstraZeneca, AbbVie, Allergan, Boehringer Ingelheim GmbH, Takeda, and many more.

2015 topics include:

  • The 21st Century Big Pharma: How Much Should Industry's Larger Players Invest in R&D?
  • Right-Sizing R&D for Optimum Productivity: What Drives Growth?
  • Improve R&D Productivity through Better Decision-Making
  • After the Acquisition: Can Big Biotechs Thrive as Research Hubs inside Big Pharma?
  • The Opportunities and Risks for Pharma in Digital Health
  • Market Access Panel: New Payment Mechanisms for Breakthrough Medicines
  • Commercial Panel: Innovating in "Mature" Markets and Finding Your Niche
  • Investor Panel: Crossover Investors at the Crossroad - A Look at Valuations, the State of Biotech Exits, and Exit Strategies
  • Business Development Panel: Checkpoint, Please! Dealmaking Intensifies in Oncology
  • Making Sure the Drug Price is Right
  • Biosimilars are here. Now What?
  • Taking Stock of Development Incentives: QIDP and Breakthrough Designation

Seats are limited and are on a first come, first served basis. To join the event, register at You can save $100 off standard rates with code PSA2015.

PSA: The Pharmaceutical Strategy Conference is the only meeting over the past 25 years to gather the industry's top thinkers to explain solutions to the fundamental challenges facing pharmaceutical and biotech companies. PSA offers case studies from senior level executives such as CEOs, Business Development executives, and heads of R&D. Not only will they share lessons learned and practical advice for finalizing a deal, but these key opinion leaders will also debate issues on enhancing R&D productivity, approaches to market access, opportunities and risks with digital health technologies, and doing more with less in business development.

To learn more about the event, visit or contact Ali Pump at

Image Available:

Contact Information